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Background: Hypertension and diabetes mellitus are increasingly common in population within Africa. We
determined the rate of coincident diabetes and hypertension and assessed the levels of co-awareness, treatment
and control in a semi-urban population in Cameroon.
Methods: A total of 1702 adults (967 women) self-selected from the community were consecutively recruited in
Bafoussam (West region of Cameroon) during November 2012. Existing diabetes and hypertension and treatments
were investigated and blood pressure and fasting blood glucose measured. Multinomial logistic regressions models
were used to investigate the determinants of prevalent diabetes and hypertension.
Results: Age-standardized prevalence rates (95% confidence intervals) men vs. women were 40.4% (34.7 to 46.1)
and 23.8% (20.4 to 27.2) for hypertension alone; 3.3% (1.5 to 5.1) and 5.6% (3.5 to 7.7) for diabetes alone; and 3.9%
(2.6 to 5.2) and 5.0% (3.5 to 6.5) for hypertension and diabetes. The age-standardized awareness, treatment and control
rates for hypertension alone were 6.5%, 86.4% and 37.2% for men, and 24.3%, 52.1% and 51.6% in women. Equivalent
figures for diabetes alone were 35.4%, 65.6% and 23.1% in men and 26.4%, 75.5% and 33.7% in women; and
those for hypertension and diabetes were 86.6%, 3.3% and 0% in men, and 74.7%, 22.6% and 0% in women. Sex,
age and adiposity were the main determinants of the three conditions.
Conclusions: Coincident diabetes and hypertension is as high as diabetes alone in this population, driven by
sex, age and adiposity. Awareness, treatment and control remain unacceptably low.
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The prevalence of type 2 diabetes mellitus is increasing
worldwide, and it is projected that the total number of
people with diabetes will rise from 366 million in 2011 to
552 million by 2030 [1]. Hypertension is also a major pub-
lic health challenge with an estimated global number of
972 million adults with the condition in 2000. This num-
ber is predicted to increase by 60% by 2025 [2,3]. Hyper-
tension affects up to 70% of individuals with diabetes and* Correspondence: apkengne@yahoo.com
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unless otherwise stated.is approximately twice as common in individuals with dia-
betes as in those without [4].
Diabetes mellitus and hypertension are among the
commonest non-communicable diseases in both devel-
oped and developing countries [5]. The coexistence of
diabetes and hypertension in the same individual varies
across different ethnic, racial, and social groups [6]. Dia-
betes is an independent risk factor for cardiovascular
disease, and the risk is markedly increased in the pres-
ence of hypertension. Furthermore, the overlap between
diabetes and hypertension in the same individuals con-
fers a greater risk of all target organ damages, general
disability and premature mortality [7]. Moreover, the fi-
nancial burden of the two conditions to patients, family
and healthcare system is huge, particularly for the fragiled. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sion, and more recently diabetes also, have been reported
across developing countries in Africa, with people residing
in urban settings being more affected [9,10]. There is also
compelling evidence that more than half of individuals
with each of the conditions at the community level are un-
aware of their status [11,12]. Furthermore, the percentages
of patients on treatment and controlled to target levels are
substantially low. Available community based reports have
largely examined hypertension and diabetes separately,
while the two conditions often coexist, share antecedents
as well as barriers to detection, treatment and control.
Community based details on the co-occurrence of hyper-
tension and diabetes in Africa are therefore needed to im-
prove the development and delivery of unified strategies
to limit their harmful effects on the health of populations.
The present study aimed to determine the prevalence
of coincident diabetes mellitus and hypertension and as-
sess the levels of co-awareness, treatment and control in
a semi urban population in Cameroon.
Methods
Study setting and population
This was a cross-sectional population-based study con-
ducted in Bafoussam, the administrative Capital of the
West Region of Cameroon. Bafoussam is a semi-urban
city undergoing rapid population expansion and socio-
economic changes. According to the year 2008 estimates
[13,14], Bafoussam had a population of about 347,517
inhabitants. The current study was based on a self-
selected sample. Between the 1st to the 10th of November
2012, daily announcements were made through two differ-
ent radio networks in the town, inviting all interested and
willing adults aged above 18 years to report to the five
screening sites distributed across the city, for screening.
Participants who reported to the screening sites were
consecutively enrolled after they had signed an in-
formed consent form. Participants were recruited from
12 to 14 November 2012, and the study was approved
by the Cameroon National Ethics Committee.
Data collection
Data collection was done simultaneously at the five screen-
ing sites by trained medical personnel during a face-to–face
interview, using standardized questionnaire. Demographic
characteristics, behavior profile, history of diabetes and
hypertension were recorded. The blood pressure (BP) was
then measured using a standardized protocol with the
participant in a seated position, and after at least 10 mi-
nutes of rest. Three serial measurements, taken 1 minute
apart, were obtained using automated sphygmomanome-
ters (OMRON M2 Basic, OMRON HEALTHCARE Co
Ltd, Kyoto, Japan). The average of the 2nd and 3rd meas-
urement was used in all analysis. Weight, height andwaist circumference (WC) were measured using stand-
ard procedures and equipment according to the World
Health Organization guidelines [15]. Weight was mea-
sured to the nearest 0.5 kg and the height to the nearest
0.5 cm. Body mass index (BMI in kg/m2) was calcu-
lated as weight (kg) / [height (m) × height (m)]. Waist
circumference (WC) was measured on the horizontal
plane midway between the lower rib margin and the
iliac crest with a measuring tape [15]. Fasting capillary
blood glucose (FCG) was measured using a glucose
meter (SD CodeFree blood glucose meter) based on
the glucose oxidase enzyme method, after an overnight
fast of at less 8 hours.
Definitions
Hypertension was defined as a systolic (SBP) ≥140 mmHg
or a diastolic blood pressure (DBP) ≥90 mmHg or on BP-
lowering medication(s) during the past two weeks [16].
Participants with hypertension were considered to be
aware of their status if they answered ‘yes’ to the question
‘Have you ever been told by a doctor or health profes-
sional that you had hypertension?’. Treatment of high BP
was defined by the use of BP-lowering medications. Dia-
betes was defined as Fasting capillary glucose ≥126 mg/dL
or previous diagnosis and on drug treatments (insulin or
oral agents) during the past two weeks. Diagnosed dia-
betes was defined as those who were diagnosed by medical
doctors or other health professionals and were on drug
treatment in the past two weeks. Individuals who reported
receiving anti-hyperglycaemic drugs in the past two weeks
were considered as being on treatment. Individuals on dia-
betes treatment were considered as being controlled if
their FCG was less than 100 mg/dL. Control target for
blood pressure was based on SBP <140 mmHg and
DBP <90 mmHg. The International Diabetes Feder-
ation (IDF) criteria [17] for African populations for
obesity was used at cut-off point of BMI ≥30 kg/m2
and abdominal obesity, defined as WC ≥94 cm for men
and ≥ 80 cm for women. People were considered to be
physically active if they reported doing at least three
sessions per week of physical activity of at less 30 mi-
nutes duration each. Moderate alcohol consumption
was considered for any intake up to seven standard
drinks per week for women and fourteen standard
drinks per week for a man; with a standard drink de-
fined as a bottle of beer or a glass of wine. Any con-
sumption above was considered to be excessive.
Statistical methods
Data analysis was carried out using the Statistical Package
for Social Sciences v.17 for Windows (SPSS Inc., Chicago,
USA). Results are summarized as count and percentages
for qualitative variables and mean and standard deviation
(SD) for quantitative variables. Individuals were categorized
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only, hypertension only, and those with coexistence of dia-
betes and hypertension. Age-standardized prevalence was
calculated using the Cameroon National population’s age
structure in 2010 as the standard population [14], and dir-
ect standardization methods [18]. Comparison of groups
was done using Chi-square tests and equivalents for quali-
tative variables, and Student t-test and analysis of the
variance (ANOVA) for quantitative variables. Multinomial
logistic regressions analyses were used to investigate poten-
tial determinants of hypertension alone, diabetes alone and
the combination of both, in age and sex adjusted analysis
and after further adjustment for potential confounders,
always using participants with none of the conditions
as a referent. Candidate predictors comprised age (cat-
egorical), sex, education, BMI (categorical), abdominal
obesity, smoking, alcohol consumption and physicalTable 1 General Characteristics of the study population
Characteristics Total
N (%) 1702 (100%)
Mean age, years (SD) 45.7 (14.0)
Age groups, years
< 35 years, n (%) 404 (23.7)
35 – 44, n (%) 415 (24.4)
45 – 54, n (%) 439 (25.8)
≥ 55, n (%) 444 (26.1)
Mean BMI, kg/m2 (SD) 28.1 (5.9)
Mean waist girth, cm (SD) 93 (42)
Mean SBP, mm Hg (SD) 141 (26)
Mean DBP, mm Hg (SD) 82 (19)
Education level
No level (1), n (%) 153 (9.0)
Primary (2), n (%) 452 (26.6)
Secondary (3), n (%) 807 (47.4)
University (4), n (%) 290 (17.0)
Ever smoking
Yes, n (%) 199 (11(7)
No, n (%) 1503 (88.3)
Alcohol consumption
No, n (%) 515 (30.3)
Moderate, n (%) 1080 (63.5)
Excessive, n (%) 107(6.3)
Physical activity
Yes, n (%) 1071 (62.9)
No, n (%) 631 (37.1)
Mean Glycemia, mg/dL 103 (40)
BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; Sactivity. A p-value <0.05 indicated statistically signifi-
cant results.
Results
General characteristics of our study population
The overall profile of the 1702 participants (967 women;
56.8%) who reported for screening in the five screening
sites is summarized in Table 1. Compared with men,
women had a similar age (45 vs. 46 years, p = 0.35), simi-
lar waist girth 92 (SD = 44) vs. 94 (41) cm (p = 0.25), but
higher BMI, 26.4 (4.5) vs. 29.3 (6.5) kg/m2 (p < 0.001).
Men were more likely to be either smokers or excessive
alcohol drinkers and more physically active (all p < 0.001).
Mean systolic and diastolic blood pressure values (SD)
at the total population level (men vs. women) were 146
(26) vs. 137 (26) mm Hg (p < 0.001), and 84 (25) vs. 81
(14) mm Hg (both p = 0.001). Equivalents figures forMen Women p-value
735 (43.2%) 967 (56.8)
46.1 (13.9) 45.4 (14.0) 0.35
0.25
174 (23.7) 230 (23.8)
170 (23.1) 245 (25.3)
182 (24.8) 257 (26.6)
209 (28.4) 235 (24.3)
26.4 (4.5) 29.3 (6.5) <0.001
92 (44) 94 (41) 0.25
146 (26) 137 (26) <0.001
84 (25) 81 (14) 0.001
<0.001
23 (3.1) 130 (13.4)
179 (24.4) 273 (28.2)
367 (49.9) 440 (45.5)
166 (22.6) 124 (12.8)
<0.001
169 (23.0) 30 (3.1)
566 (77.0) 937 (96.9)
<0.001
130 (17.7) 385 (39.8)
508 (69.1) 572 (59.2)
97 (13.2) 10 (1.0)
<0.001
542 (73.7) 529 (54.7)
193 (26.3) 438 (45.3)
101 (42) 104 (38) 0.14
D, standard deviation.
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(p = 0.14).
Prevalence of hypertension and diabetes
The age standardized prevalence men vs. women and
the accompanying 95% confidence intervals were 40.4%
(34.7 to 46.1) and 23.8% (20.4 to 27.2) for hypertension
alone; 3.3% (1.5 to 5.1) and 5.6% (3.5 to 7.7) for diabetes
alone; and 3.9% (2.6 to 5.2) and 5.0% (3.5 to 6.5) for
hypertension and diabetes (Table 2). The crude preva-
lence of hypertension alone increased from 33.3% (men)
and 13.4% (women) in the age group <35 years, up to
61.2% (men) and 51.9% (women) in the age group 55 years
and above (both p < 0.001 for linear trend; Table 2).
The crude prevalence of hypertension and diabetes in-
creased from 1.1% (men) and 2.2% (women) in the age
group <35 years up to 13.4% (men) and 16.2% (women)
in the age group 55 years and above (both p < 0.001 for
linear trends). However, the crude prevalence of dia-
betes alone tended to decrease with increasing age and
in a linear fashion (both p < 0.001 for linear trend,
Table 2).
Awareness, treatment and control of hypertension and
diabetes
The age-standardized awareness, treatment and control
rates for hypertension alone were 6.5%, 86.4% and 37.2%
for men, and 24.3%, 52.1% and 51.6% in women (Table 2).
Equivalent figures for diabetes alone were 35.4%, 65.6%
and 23.1% in men and 26.4%, 75.5% and 33.7% in women;
and those for hypertension and diabetes were 86.6%, 3.3%
and 0% in men, and 74.7%, 22.6% and 0% in women. The
crude prevalence of awareness increased with increasing
age for hypertension alone in men (p < 0.001 for linear
trend), while that for hypertension and diabetes decreased
with increasing age in women (p = 0.016). A borderline
decreasing trend of treatment with increasing age was ob-
served for diabetes alone in women (p = 0.06 for linear
trend), otherwise, trend in treatment rates was generally
non-significant (all p ≥ 0.23 for linear trend). Control rate
among those with hypertension alone increased with in-
creasing age both in men (p = 0.024 for linear trend) and
women (p = 0.031).
Predictors of hypertension and diabetes
In age and sex adjusted multinomial logistic regressions
models and using participants with none of the condi-
tions as a reference group, male sex was associated with
odd ratios (95% confidence interval) of 1.73 (1.39-2.16)
for hypertension alone, 0.70 (0.42-1.19) for diabetes alone
and 1.08 (0.72-1.60). The risk of hypertension alone, or
hypertension and diabetes steadily increased with increas-
ing age, with an apparent multiplicative effect of age on
the risk of each of the conditions. The increasing risk ofdiabetes alone with age was apparent only when compar-
ing participants in the upper age stratum (≥55 years) with
those in the lower stratum (<35 years), with an odd ratio
of 2.35 (1.20-4.61). Abdominal obesity was associated with
odd ratio (95% CI) of 1.48 (1.12-1.94) for hypertension
alone, 2.23 (1.13-4.40) for diabetes alone and 2.20 (1.34-
3.60) for diabetes and hypertension (Table 3). The odds of
hypertension alone, or hypertension with diabetes in-
creased across BMI categories, while a significantly higher
odd of diabetes alone was observed only for obese vs. nor-
mal weight participants [OR 2.04 (95% CI 1.08-3.86)].
Moderate alcohol consumption was associated with re-
duced odd of diabetes and hypertension [OR 0.58 (95% CI
0.38-0.88)], however the overall effect of alcohol con-
sumption on the risk of the three outcomes was non-
significant (p = 0.11 for the likelihood ratio chi square
test). In expanded multivariable model, only sex, age and
BMI categories were associated with the risk of the out-
comes. The odd ratios from the final model comprising
the three predictors are shown in Table 4.
Discussion
This study has revealed the co-occurrence of hyperten-
sion and diabetes to be at least as frequent as diabetes
alone. The study has further confirmed the high preva-
lence of hypertension in this population. While the pres-
ence of the three conditions appeared to be linked with
increasing age and adiposity, effects on the risk of dia-
betes alone were significant only at the upper tail of the
distribution of both characteristics. Within strata of age
or BMI, the magnitude of the risk of diabetes and hyper-
tension always appeared to be higher than that for hyper-
tension alone, while a multiplicative effect was evident
across age strata. Over ¾ of participants with diabetes and
hypertension were aware of their condition, while only
about 1/3rd of those with diabetes alone and less than ¼ of
those with hypertension alone were aware of their condi-
tion. Less than one in every five patients aware of their
hypertension and diabetes was on co-treatment for the
two conditions, against 2/3rd or more for those with either
of the conditions. Control rates among patients co-treated
for diabetes and hypertension was insignificant, and
ranged from 1/4th to about half among those treated
for either of the conditions. However, some of these
figures were based on small numbers, hence the in-
stability of the estimates.
The coexistence of diabetes and hypertension in the
clinical setting has been extensively reported and de-
scribed as a “toxic combination” that increases risks of
cardiovascular diseases, renal complications, and retin-
opathy [19,20]. Choukem et al. [21] reported that 66.7%
of diabetic patients in a clinical setting in Cameroon exhibit
hypertension which is about three times more frequent
than the general population. Contrariwise, community




Age groups (years) p-trend Overall Overall
standardized
Age groups (years) p-trend
<35 35-44 44-55 ≥55 <35 35-44 44-55 ≥55
N 735 174 170 182 209 967 230 245 257 235
Hypertension alone
SBP/DBP ≥ 140/90 or treatment (n) 359 58 67 106 128 345 31 69 123 122
Prevalence (%) 48.8 40.4 (34.7 to 46.1) 33.3 39.4 58.2 61.2 <0.001 35.7 23.8 (20.4 to 27.2) 13.5 28.2 47.9 51.9 <0.001
Among hypertensives (n) 53 1 2 22 28 94 7 17 36 34
Awareness (%) 14.8 6.5 (3.9 to 9.1) 1.7 3.0 20.7 21.9 <0.001 38.4 24.3 (13.6 to 35.0) 22.6 24.6 29.3 27.9 0.49
Among aware hypertensives (n) 40 1 1 16 22 64 3 10 24 27
Treatment (%) 74.5 86.4 (−34.1 to 206.9) 100 50.0 72.7 78.6 0.67 68.1 52.1 (21.0 to 83.2) 42.9 58.8 66.7 79.4 0.031
Among treated hypertensives 36 0 1 14 21 51 1 8 19 23
Control (%) 90.0 37.2 (5.1 to 69.3) 0 100 87.5 95.4 0.024 79.7 51.6 (9.6 to 93.6) 33.3 80.0 79.2 85.2 0.13
Diabetes alone
FBS > 126 mg/dl or treatment (n) 22 6 7 4 5 51 14 10 14 13
Prevalence (%) 3.0 3.3 (1.5 to 5.1) 3.4 4.1 2.3 2.4 <0.001 5.3 5.6 (3.5 to 7.7) 6.1 4.1 5.4 5.5 <0.001
Among diabetics (n) 8 2 1 2 3 17 3 2 5 7
Awareness (%) 36.4 35.4 (4.8 to 66.0) 33.3 14.3 50.0 60.0 0.23 33.3 26.4 (9.7 to 43.1) 21.4 20.0 35.7 53.8 0.06
Among aware diabetics (n) 6 1 1 2 2 14 2 2 4 6
Treatment (%) 75.0 65.6 (−4.4 to 135.6) 50.0 100 100 66.7 0.750 82.3 75.5 (12.9 to 138.1) 66.7 100 80.0 85.7 0.65
Among treated diabetics (n) 4 0 0 2 2 10 0 2 4 4
Control (%) 66.7 23.1 (0.4 to 45.8) 0 0 100 100 0.048 71.4 33.7 (8.5 to 58.9) 0 100 100 66.7 0.29
Hypertension & diabetes
SBP/DBP ≥ 140/90 or BP treatment
& FBS > 126 mg/dl or diabetes
treatment (n)
51 2 8 13 28 78 5 13 22 38
Prevalence (%) 6.9 3.9 (2.6 to 5.2) 1.1 4.7 7.1 13.4 <0.001 8.1 5.0 (3.5 to 6.5) 2.2 5.3 8.6 16.2 <0.001
Among diabetic hypertensives (n) 35 2 6 5 22 46 4 11 13 18
Awareness (%) 68.6 86.6 (1.5 to 171.7) 100 75.0 38.5 78.6 0.73 59.0 74.7 (25.0 to 124.4) 80.0 84.6 59.1 47.4 0.016
Among aware diabetic hypertensives (n) 3 0 0 1 2 11 1 0 4 6
Treatment (%) 8.6 3.3 (−1.3 to 7.9) 0 0 20.0 9.1 0.24 23.9 22.6 (−8.3 to 53.5) 25.0 0 30.8 33.3 0.46
Among treated diabetic hypertensives (n) 0 0 0 0 0 0 0 0 0 0
Control (%) 0 0 NA NA 0 0 NA 0 0 0 NA 0 0 NA



















Table 3 Age and sex adjusted multinomial logistic regressions for determinants of hypertension alone, diabetes alone
or the combination of both




(p-value)OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Sex Men 1.00 (reference) 1.73 (1.39-2.16) <0.001 0.70 (0.42-1.19) 0.19 1.08 (0.72-1.60) 0.72 <0.001
Age (years) <0.001
< 35 years 1.00 (reference) 1.00 (reference) NA 1.00 (reference) NA 1.00 (reference) NA
35 – 44 years 1.00 (reference) 1.86 (1.35-2.57) <0.001 1.00 (0.51-1.96) 0.99 3.59 (1.50-8.60) 0.004
45 – 54 years 1.00 (reference) 4.88 (3.56-6.69) <0.001 1.62 (0.83-3.15) 0.16 9.21 (4.00-21.23) <0.001
≥ 55 years 1.00 (reference) 7.39 (5.32-10.28) <0.001 2.35 (1.20-4.61) 0.013 24.70 (10.99-55.50) <0.001
Education level 0.82
None 1.00 (reference) 1.00 (reference) NA 1.00 (reference) NA 1.00 (reference) NA
Primary 1.00 (reference) 0.98 (0.62-1.55) 0.93 0.51 (0.21-1.26) 0.14 0.81 (0.42-1.55) 0.52
Secondary 1.00 (reference) 1.14 (0.71-1.83) 0.57 0.49 (0.19-1.24) 0.13 0.96 (0.48-1.90) 0.90
University 1.00 (reference) 1.02 (0.60-1.74) 0.93 0.61 (0.21-1.77) 0.37 0.80 (0.33-1.93) 0.80
Smoking 0.13
Yes 1.00 (reference) 0.73 (0.51-1.04) 0.08 1.57 (0.72-3.40) 0.25 0.97 (0.53-1.77) 0.92
Alcohol consumption 0.11
No 1.00 (reference) 1.00 (reference) NA 1.00 (reference) NA 1.00 (reference) NA
Moderate 1.00 (reference) 0.88 (0.68-1.13) 0.31 0.85 (0.51-1.43) 0.55 0.58 (0.38-0.88) 0.010
Excessive 1.00 (reference) 0.87 (0.53-1.42) 0.58 0.22 (0.03-1.75) 0.15 0.39 (0.14-1.09) 0.074
Physical activity Yes 1.00 (reference) 1.01 (0.80-1.27) 0.93 0.74 (0.45-1.22) 0.24 1.26 (0.83-1.91) 0.27 0.40
Body mass index (kg/m2) <0.001
<25 kg/m2 1.00 (reference) 1.00 (reference) NA 1.00 (reference) NA 1.00 (reference) NA
25 – 29.9 kg/m2 1.00 (reference) 1.73 (1.32-2.26) <0.001 1.27 (0.68-2.36) 0.45 2.12 (1.26-3.57) 0.005
≥30 kg/m2 1.00 (reference) 2.31 (1.71-3.13) <0.001 2.04 (1.08-3.86) 0.029 3.94 (2.27-6.82) <0.001
Abdominal obesity
Yes 1.00 (reference) 1.48 (1.12-1.94) 0.005 2.23 (1.13-4.40) 0.14 2.20 (1.34-3.60) 0.002 0.002
NA, not applicable; OR, odd ratio; 95% CI, 95% confidence interval.
Table 4 Multivariable adjusted multinomial logistic regressions for determinants of hypertension alone, diabetes alone
or the combination of both
Variable Categories None Hypertension alone Diabetes alone Diabetes and hypertension Likelihood
ratio test
(p-value)
OR (95% CI) p-value OR (95% CI) p-value OR (95% CI) p-value
Sex Men 1.00 (reference) 2.04 (1.62-2.57) <0.001 0.82 (0.48-1.41) 0.48 1.41 (0.93-2.14) 0.14 <0.001
Age (years) <0.001
< 35 years 1.00 (reference) 1.00 (reference) NA 1.00 (reference) NA 1.00 (reference) NA
35 – 44 years 1.00 (reference) 1.65 (1.19-2.29) 0.002 0.90 (0.46-1.77) 0.75 2.95 (1.23-7.10) 0.016
45 – 54 years 1.00 (reference) 4.39 (3.19-6.04) <0.001 1.48 (0.76-2.91) 0.25 7.81 (3.37-18.08) <0.001
≥ 55 years 1.00 (reference) 7.69 (5.51-10.74) <0.001 2.43 (1.23-4.77) 0.010 26.32 (11.66-59.40) <0.001
Body mass index (kg/m2) <0.001
<25 kg/m2 1.00 (reference) 1.00 (reference) NA 1.00 (reference) NA 1.00 (reference) NA
25 – 29.9 kg/m2 1.00 (reference) 1.73 (1.32-2.26) <0.001 1.27 (0.68-2.36) 0.45 2.12 (1.26-3.57) 0.005
≥30 kg/m2 1.00 (reference) 2.31 (1.71-3.13) <0.001 2.04 (1.08-3.86) 0.029 3.94 (2.27-6.82) <0.001
NA, not applicable; OR, odd ratio; 95% CI, 95% confidence interval.
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http://www.biomedcentral.com/1471-2458/14/696studies focusing on the prevalence of this “toxic com-
bination, have been less well reported in sub-Saharan
Africa. Some randomized control trial studies have
demonstrated that aggressive control of blood glucose
and blood pressure could improve the CVD outcomes
[22]. Therefore early detection and control of the coex-
isting of both diseases is primordial and key to the re-
duction of related morbi-mortality. Our study revealed
that more than 50% of the participants with the coex-
istence of both conditions were aware of their status
but with less than 30% of individuals with both condi-
tions being treated. None of the individuals with both
conditions who were treated was simultaneously con-
trolled. These figures are similar to those reported
elsewhere [23] and therefore emphasize the need for a
more pro-active approach to hypertension and diabetes
prevention, detection, treatment and control in this
setting. Possible drivers of the low awareness, detection,
treatment and control of hypertension and diabetes in
Cameroon and which could apply to the current study,
have been extensively discussed previously [24,25].
There are some limitations to this study. First is the self-
selected nature of participants that may not necessarily be
representative of the city population. We attempted to
achieve this by using an almost universal mass media for
sensitization. However, we cannot rule out the possibility
that participants in the study could still differ from the
general population by being more or less health conscious,
and having less severe disease for example, which could
affect some parameters in the study, including the accur-
acy of our prevalence estimates. Therefore, caution should
be exercised when extrapolation our estimates to a
broader population in the same setting. Secondly, this
study might have underestimated the true prevalence
of diabetes since only fasting glucose test was used,
and given that the two-hour glucose tolerance test has
been reported to be more accurate in the detection of
undiagnosed diabetes. However the fasting glucose test
was more feasible to perform in this population-based
study. Secondly, the diagnosis of hypertension was based
on BP measurements during one single encounter which
does not coincide with the current recommendation of
using two measurements recorded on three separate occa-
sions [26]. This may have overestimated the prevalence of
hypertension and underestimated the level of BP control.
Nevertheless, our study was based on a larger sample of
participants from area not traditionally extensively covered
by major previous population-based surveys in Cameroon.
We have further used standardized measurement proce-
dures to collect data in an accurate and reproducible way,
and used robust analytic methods to generate estimates
which will facilitate comparisons with evidence from else-
where. Lastly, we didn’t assess the nutritional status
which is a well-known major confounding factor forboth hypertension and diabetes mellitus; nor did we
collect the individual level data to investigate the de-
terminants of detection, treatment and control of the
two conditions in our population.
Conclusions
In conclusion, high prevalence rates of diabetes and hyper-
tension were observed in this population of self-selected
semi-urban subjects. Increased age and BMI were found to
be important risk factors for all these disorders. Integrated
prevention, detection and control programs targeting both
conditions and other major risk factors for cardiovascular
diseases can potentially help to reverse the observed
trends. However, locally relevant effective components of
such programs have yet to be developed and fully tested.
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